U.S. Pharmaceutical Giant Uses AI to Accelerate Discovery of New Medicines

U.S. Pharmaceutical Giant Uses AI to Accelerate Discovery of New Medicines
——————————
A major U.S. pharmaceutical company is taking a new step to accelerate the discovery and development of new medicines by using artificial intelligence models.

The move reflects the growing role of technology in the global healthcare and pharmaceutical industries.

According to Fana, Bristol Myers Squibb has announced that it will make Anthropic’s AI model Claude available to more than 30,000 of its employees in order to speed up drug discovery and development processes.

Reuters also reported that many pharmaceutical companies around the world hope artificial intelligence will help increase the success rate of new drug development and reduce the time needed to bring medicines to market.